
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
Hiroki Kitakata, Jin Endo, Hidehiko Ikura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 100
Hiroki Kitakata, Jin Endo, Hidehiko Ikura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 100
Showing 1-25 of 100 citing articles:
Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
Lai‐Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2726-2726
Open Access | Times Cited: 97
Lai‐Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2726-2726
Open Access | Times Cited: 97
Regulated cell death pathways in cardiomyopathy
Shuyuan Sheng, Jiamin Li, Xinyang Hu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1521-1535
Closed Access | Times Cited: 67
Shuyuan Sheng, Jiamin Li, Xinyang Hu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 8, pp. 1521-1535
Closed Access | Times Cited: 67
Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease
Yan Qian, Shasha Liu, Yang Sun, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Yan Qian, Shasha Liu, Yang Sun, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 58
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 58
The Dual Roles of Activating Transcription Factor 3 (ATF3) in Inflammation, Apoptosis, Ferroptosis, and Pathogen Infection Responses
Shuang Liu, Zhangcheng Li, Shimei Lan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 824-824
Open Access | Times Cited: 37
Shuang Liu, Zhangcheng Li, Shimei Lan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 824-824
Open Access | Times Cited: 37
Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy
Chuying Huang, Yishan Guo, Tuo Li, et al.
Redox Biology (2024) Vol. 70, pp. 103024-103024
Open Access | Times Cited: 21
Chuying Huang, Yishan Guo, Tuo Li, et al.
Redox Biology (2024) Vol. 70, pp. 103024-103024
Open Access | Times Cited: 21
Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage
Bozhi Ye, Xiaowen Shi, Jianjiang Xu, et al.
Translational research (2022) Vol. 248, pp. 36-50
Closed Access | Times Cited: 52
Bozhi Ye, Xiaowen Shi, Jianjiang Xu, et al.
Translational research (2022) Vol. 248, pp. 36-50
Closed Access | Times Cited: 52
The role of adiponectin in cardiovascular disease
Peng Jin, Qian Chen, Chuncao Wu
Cardiovascular Pathology (2023) Vol. 64, pp. 107514-107514
Closed Access | Times Cited: 33
Peng Jin, Qian Chen, Chuncao Wu
Cardiovascular Pathology (2023) Vol. 64, pp. 107514-107514
Closed Access | Times Cited: 33
Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3–NFS1 axis in doxorubicin-induced cardiotoxicity
Yifan Wang, Xiaoying Ying, Yuehong Wang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110655-110655
Closed Access | Times Cited: 25
Yifan Wang, Xiaoying Ying, Yuehong Wang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110655-110655
Closed Access | Times Cited: 25
Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity
Yinghua Zeng, Xu Liao, Yuting Guo, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 838-848
Closed Access | Times Cited: 11
Yinghua Zeng, Xu Liao, Yuting Guo, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 838-848
Closed Access | Times Cited: 11
DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 10
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 10
Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy
Debiao Xiang, Lili Zhou, Ruizhen Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2091-2112
Open Access | Times Cited: 9
Debiao Xiang, Lili Zhou, Ruizhen Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2091-2112
Open Access | Times Cited: 9
GSH and Ferroptosis: Side-by-Side Partners in the Fight against Tumors
Yulang Jiang, Christian Glandorff, Mingyu Sun
Antioxidants (2024) Vol. 13, Iss. 6, pp. 697-697
Open Access | Times Cited: 8
Yulang Jiang, Christian Glandorff, Mingyu Sun
Antioxidants (2024) Vol. 13, Iss. 6, pp. 697-697
Open Access | Times Cited: 8
Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes
M. Mao, Zheng Wang, Bin Deng, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292124-e0292124
Open Access | Times Cited: 18
M. Mao, Zheng Wang, Bin Deng, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292124-e0292124
Open Access | Times Cited: 18
USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy
Dongchen Wang, Zihao Jiang, Junyan Kan, et al.
Cellular Signalling (2024) Vol. 117, pp. 111070-111070
Closed Access | Times Cited: 7
Dongchen Wang, Zihao Jiang, Junyan Kan, et al.
Cellular Signalling (2024) Vol. 117, pp. 111070-111070
Closed Access | Times Cited: 7
Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches
Kexin Cai, Haoyue Jiang, Yuanming Zou, et al.
Pharmacological Research (2024) Vol. 206, pp. 107281-107281
Open Access | Times Cited: 7
Kexin Cai, Haoyue Jiang, Yuanming Zou, et al.
Pharmacological Research (2024) Vol. 206, pp. 107281-107281
Open Access | Times Cited: 7
MG53 inhibits ferroptosis by targeting the p53/SLC7A11/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity
Wenhua Jiang, Lu Yu, Nan Mu, et al.
Free Radical Biology and Medicine (2024) Vol. 223, pp. 224-236
Closed Access | Times Cited: 7
Wenhua Jiang, Lu Yu, Nan Mu, et al.
Free Radical Biology and Medicine (2024) Vol. 223, pp. 224-236
Closed Access | Times Cited: 7
FGF12 restrains mitochondria‐dependent ferroptosis in doxorubicin‐induced cardiomyocytes through the activation of FGFR1/AMPK/NRF2 signaling
Ge Tian, Jing Li, Wenjie Wang, et al.
Drug Development Research (2024) Vol. 85, Iss. 1
Closed Access | Times Cited: 6
Ge Tian, Jing Li, Wenjie Wang, et al.
Drug Development Research (2024) Vol. 85, Iss. 1
Closed Access | Times Cited: 6
The m6A demethylase fat mass and obesity-associated protein mitigates pyroptosis and inflammation in doxorubicin-induced heart failure via the toll-like receptor 4/NF-κB pathway
Weiling Tu, Xiao Huang, Song‐Tao Liu, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 158-173
Open Access | Times Cited: 6
Weiling Tu, Xiao Huang, Song‐Tao Liu, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 158-173
Open Access | Times Cited: 6
Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: The mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway
Z H Zhang, Zhihua Yang, Shuai Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118264-118264
Closed Access | Times Cited: 6
Z H Zhang, Zhihua Yang, Shuai Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118264-118264
Closed Access | Times Cited: 6
The mechanism and therapeutic strategies in Doxorubicin induced cardiotoxicity: Role of programmed cell death
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 6
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 6
Biomimetic Nanozymes Suppressed Ferroptosis to Ameliorate Doxorubicin-Induced Cardiotoxicity via Synergetic Effect of Antioxidant Stress and GPX4 Restoration
Yunpeng Zhang, Shuang Liu, Jing Peng, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1090-1090
Open Access | Times Cited: 13
Yunpeng Zhang, Shuang Liu, Jing Peng, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1090-1090
Open Access | Times Cited: 13
Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3
Jingmei Zhang, Weili Li, Siming Xue, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117134-117134
Closed Access | Times Cited: 13
Jingmei Zhang, Weili Li, Siming Xue, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117134-117134
Closed Access | Times Cited: 13
Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study
Farshid Maleki, Shahram Rabbani, Reza Shirkoohi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115651-115651
Open Access | Times Cited: 13
Farshid Maleki, Shahram Rabbani, Reza Shirkoohi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115651-115651
Open Access | Times Cited: 13
Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysis
Jaili Li, Ting Luo, Yao Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116748-116748
Open Access | Times Cited: 5
Jaili Li, Ting Luo, Yao Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116748-116748
Open Access | Times Cited: 5